The Top Line

The most anticipated drug launches of 2024

5 snips
Feb 9, 2024
Guest
Ayla Ellison
Guest
Ben Adams
Editor-in-Chief Ayla Ellison and Fierce Pharma Marketing Senior Editor Ben Adams discuss the most anticipated drug launches of 2024, including a schizophrenia drug awaiting FDA approval, Bristol Myers Squibb's targeted launch plan, and Madrigal Pharmaceuticals' goal to become a leader in liver health.
Ask episode
Chapters
Transcript
Episode notes
1
Introduction
00:00 • 2min
2
Declining Anticipated Sales and Complexity of Drug Launches
02:05 • 2min
3
Decline in Anticipated Drug Launches and Spotlight on CAR XT for Schizophrenia
03:46 • 2min
4
Eli Lilly's Alzheimer's Hopeful Drug and its Anticipation for 2024 Launch
05:44 • 2min
5
Potential Drug Approvals for Alzheimer's and NASH
07:46 • 3min